Skip to main content
Clinical Trials/NCT04614155
NCT04614155CompletedNot Applicable

Texas State HPV Self-Collection Pilot Study

M.D. Anderson Cancer Center2 sites in 1 country40 target enrollmentStarted: August 27, 2019Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
40
Locations
2
Primary Endpoint
Human papillomavirus (HPV) self-collection uptake rate

Study Overview

Brief Summary

This trial studies if Project Self can improve the rate of cervical cancer screening in Hispanic and African American women living in Houston, Texas. Project Self may help to improve cervical cancer screening rates by providing human papillomavirus (HPV) self-collection kits, education, counseling, and navigation.

Detailed Description

PRIMARY OBJECTIVES:

I. To examine the feasibility of conducting an education intervention trial regarding cervical cancer screening among women of Hispanic and African American origin living in public housing units in Houston, Texas.

SECONDARY OBJECTIVES:

I. Document cervical screening associated knowledge, attitudes and practices among Hispanic and African American women living in public housing units in Houston, Texas at pre- and post-health education.

II. Document Pap smear screening rate in last 3 years among participants. III. Document HPV positive rate among participants.

Study Design

Study Type
Interventional
Allocation
Na
Intervention Model
Single Group
Primary Purpose
Screening
Masking
None

Eligibility Criteria

Ages
30 Years to 65 Years (Adult, Older Adult)
Sex
Female
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • Self-identify as African American or Hispanic women.
  • Valid home address reflective of residence in the participating housing development(s) at least 50% of the time.
  • Functioning telephone number.
  • Speak and read English or Spanish.

Exclusion Criteria

  • Self-reported hysterectomy.
  • Self-reported personal history of cancer/cancer diagnosis.
  • Self-reported as pregnant.
  • Another household member is enrolled in this protocol.

Outcomes

Primary Outcomes

Human papillomavirus (HPV) self-collection uptake rate

Time Frame: Up to 2 weeks after health education session

Defined as the proportion of the participants who consent to the study and receive an HPV self-collection kit complete the self-collection and return the sample to the lab or research staff member or community health worker within timeline.

Participant consent rate

Time Frame: Up to 1 month

Secondary Outcomes

  • HPV positive proportion(Up to 1 month)
  • Cervical screening associated knowledge, attitudes and practices score(Up to 1 month)
  • Participants' self-reported Pap smear screening rate in last 3 years(Up to 1 month)

Investigators

Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (2)

Loading locations...

Similar Trials

Project Self in Improving Cervical Cancer... | Clinical Trial